Pharmaceutical Technology

APRIL 24, 2023

. “Biologics products may contain proteins that control the action of other proteins and cellular processes, genes that control production of vital proteins, modified human hormones, or cells that produce substances that suppress or activate components of the immune system. Please check your email to download the Whitepaper.

Vaccines 52

Vaccines Compounding Communication Immunity 52

Pharmaceutical Technology

APRIL 24, 2023

With early nanoparticle studies, researchers often found the human body’s innate immune response to drugs and the short-lasting effects of drugs challenging, as they can also reduce a drug’s efficacy. GlobalData predicts that Comirnaty’s sales will increase by more than 20% between 2024 and 2027.

Vaccines 59

Vaccines Immunity Immunization Medical Schools 59

Pharmaceutical Technology

JUNE 21, 2023

With this pipeline, Empress hopes to address unmet clinical needs in immune and inflammatory conditions, and metabolic, neurologic, oncologic, and pain disorders. Analysts forecast the biologics market to be worth $120 billion more than small molecules by 2027. Murray KcKinnon, PhD He joined Empress as chief scientific officer.

Compounding 52

Compounding Communication Immunity Immunization 52